Home / Import refusals / 8NP-0055992-6/11/1

8NP-0055992-6/11/1

AstraZeneca UK Ltd. — FEI 3002850317

Recent inspections

  • 1274179 (VAI Thu Apr 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1129231 (VAI Sun Feb 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017549 (NAI Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 878183 (VAI Fri Apr 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785250 (VAI Fri Mar 16 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • F23-9340161-7/110002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • F23-9339962-1/80002/1 (Wed Sep 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7278562-1/11/1 (Thu May 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8259678-2/11/1 (Thu Feb 27 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7048191-7/11/1 (Mon Nov 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
February 9, 2021
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
62ZCL37 OLAPARIB (ANTI-NEOPLASTIC - PART II)
Charges
118,2280,3280,75